Europe Regulator Addresses Pradaxa Bleeding Deaths
Europe Regulator Addresses Pradaxa Bleeding Deaths However, the European Medicines Agency (EMA) said that new prescribing recommendations issued last week would mitigate the Pradaxa bleeding risk. Those recommendations advised doctors to subject Pradaxa patients older than 75, as well as those with renal impairment, to annual … [Read more...]
Use of Multaq Should be Curbed
Multaq Safety Issues. Multaq safety worries have prompted regulators to issue new restrictions for the drug. According to a report from The Wall Street Journal, concerns about Multaq's impact on the heart, lungs and liver might soon prompt the U.S. Food & Drug Administration (FDA) to take similar steps in the … [Read more...]
BP Oil Spill Regulator Institutes Ethics Policy
In The Wake Of BP Oil Spill, BOEM Imposed Ethics Policy. In the wake of the BP oil spill, the Bureau of Ocean Energy Management is imposing its first-ever ethics policy. The Bureau of Ocean Management was formed over the summer, after the functions of the scandal-plagued Minerals Management Service (MMS) were divided. The Bureau … [Read more...]
German Drug Regulator Rejected Avandia
A German regulator has rejected Avandia, directing health insurers in that country to stop paying for GlaxoSmithKline’s controversial diabetes drug. The decision comes just a month before a U.S. Food & Drug Administration (FDA) advisory panel meeting is held on Avandia. commission commission The ban on glitazone medicines … [Read more...]
Regulator: Report On Enron ‘Solid’
Enron Price Manipulation and Deceit. However, Pat Wood, chairman of the Federal Energy Regulatory Commission, said at a news conference that his agency's report was a first step and regulators are still conducting their investigation, which could result in other energy companies being cited for their practices. "It's an initial … [Read more...]
